Finally, anti-MDA5 (also known as anti-CADM140) were claimed to mark a DM variant with low grade/absent muscle inflammation (amyiopathic dermatomyositis) but severe skin manifestations, hyperferritinemic status, frequent and rapidly progressive interstitial lung disease (ILD) and poor prognosis [28–31]. Here, IFIH1 is linked to interstitial lung disease.